About Ardena
Ardena is a company based in Frankfurt Am Main (Germany) founded in 2017 was acquired by GHO Capital Partners in January 2020. Ardena has completed 3 acquisitions, including ChemConnection, Idifarma and Syntagon. Ardena offers products and services including Drug Substance Services, Bioanalysis Services, Drug Product Services, and Clinical Supply Services. Ardena operates in a competitive market with competitors including Almac Group, Asymchem, Seqens, Aurobindo Pharma and Aptuit, among others.
- Headquarter Frankfurt Am Main, Germany
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website ardena.com
- Social LinkedIn
- Acquired by GHO Capital Partners (Jan 2020)
- Legal Name Ardena Holding Nv
- Investors
- Investments & AcquisitionsChemConnection
& 2 more
- Acquired byGHO Capital Partners
(Jan 2020)
Products & Services of Ardena
Ardena offers a comprehensive portfolio of products and services, including Drug Substance Services, Bioanalysis Services, Drug Product Services, and Clinical Supply Services.
Develops and manufactures drug substances for pharmaceutical use
Conducts expert testing for preclinical and clinical drug stages
Formulates and stabilizes drug products for clinical trials
Handles packaging and logistics for clinical trial materials
Investors in Ardena
Ardena has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include GHO Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Specialist healthcare investment advisory services are provided by GHO Capital. | – | ghocapital.com | London, United Kingdom |
Investor details for Ardena
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ardena
Ardena has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include ChemConnection, Idifarma and Syntagon.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Drugs are developed and manufactured in various dosage forms. | idifarma.com | Pamplona, Spain | 2001 | Sep 2021 | •••• | |
Limited information available | syntagon.se | Sodertalje, Sweden | 1998 | May 2018 | •••• | |
Nanomedicines and pharmaceutical products are developed and manufactured. | chemconnection.eu | Oss, Netherlands | 2012 | Mar 2018 | •••• |
Complete acquisition details for Ardena
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Ardena
5 dated milestones of Ardena across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Ardena is founded.
- Acquisition Acquires ChemConnection.
- Acquisition Acquires Syntagon.
- Exit Acquired by GHO Capital Partners.
- Acquisition Acquires Idifarma.
Competitors of Ardena
Ardena operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Asymchem, Seqens, Aurobindo Pharma and Aptuit, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| almacgroup.com | 2001 | Craigavon, United Kingdom | $338.8M | 2,109 | Integrated CDMO services for biopharma R&D and manufacturing are offered. | |
| asymchem.com | 1995 | Morrisville, United States | – | 48 | APIs and peptides are developed and manufactured by Asymchem. | |
| seqens.com | 2003 | Ecully, France | – | 44 | Contract manufacturing services for small molecules and peptides are provided. | |
| aurobindo.com | 1986 | Hyderabad, India | – | 1,010 | Generic biocatalytic solutions are provided for pharmaceutical applications. | |
| aptuit.com | 2004 | Greenwich, United States | $14.23M | – | Contract research and development services for small molecules are offered. | |
| indoco.com | 1947 | Mumbai, India | – | 6,291 | APIs manufacturing and formulation services are provided in therapeutic segments. | |
| concordbiotech.com | 2000 | Ahmedabad, India | – | 1,598 | APIs and enzymes are manufactured through fermentation by the CDMO. | |
| continuuspharma.com | 2012 | Woburn, United States | $7.73M | 47 | MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development | |
| pharm-int.com | 1994 | Hunt Valley, United States | $171.23M | 248 | Pharmaceutical dosage forms are manufactured by this CDMO. |
Detailed competitors of Ardena
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Ardena
The website of Ardena (ardena.com) receives about 12.2K visits a month and ranks #1,448,848 among all websites worldwide, #1,886 in Biotechnology and Pharmaceuticals.
- Monthly visits12.2K
▼ 9.6% vs previous month
- Unique visitors5.8K
per month
- Global rank#1,448,848
among all websites
- Category rank#1,886
Health · Biotechnology and Pharmaceuticals
- Bounce rate37%
- Pages per visit3.2
- Average visit1 min 01 sec
- DevicesDesktop 32% · Mobile 68%
Websites whose visitors overlap most with Ardena. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
pharmaceuticalmanufacturer.media | pharmaceuticalmanufacturer.media | 100% | – | #1,499,999 | – |
| almacgroup.com | 97% | 63.1K | #547,621 | View details | |
| catalent.com | 88% | 116.7K | #338,870 | View details |
Latest news on Ardena
Complete news archive for Ardena
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Ardena
10 companies that operate in the same segment as Ardena (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ardena
Ardena was founded in 2017.
Ardena is headquartered in Frankfurt Am Main, Germany. It is registered at Frankfurt Am Main, Hesse, Germany.
Ardena, formed by the merger of Pharmavize and Crystallics in 2017 is a CDMO with expertise in formulation development and crystallization RD services. While Pharmavize has expertise in areas such as Lipid-based formulations, nanonization, spray drying and hot-melt extrusion, Crystallics has expertise in solid form screening and selection, crystallization process support, X-ray based crystal structure studies. The company claims that their clientele ranges from emerging biotech startups to tier-one pharmaceutical companies in Europe, the United States, Japan, and South Korea.
Ardena's top competitors include Concord Biotech, Almac Group and Indoco Remedies.
Ardena offers Drug Substance Services, Bioanalysis Services, Drug Product Services, and Clinical Supply Services.
Ardena has made 3 acquisitions, including ChemConnection, Idifarma, and Syntagon.
Ardena has 1 investor. Key investors include GHO Capital.
Ardena operates through Ardena Holding Nv.
Yes. Ardena was acquired by GHO Capital Partners in January 2020.